Detalles de la búsqueda
1.
Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up.
Clin Sci (Lond);
136(1): 139-161, 2022 01 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34878093
2.
Prodrug of ICRF-193 provides promising protective effects against chronic anthracycline cardiotoxicity in a rabbit model in vivo.
Clin Sci (Lond);
135(15): 1897-1914, 2021 08 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34318878
3.
Investigation of Structure-Activity Relationships of Dexrazoxane Analogs Reveals Topoisomerase IIß Interaction as a Prerequisite for Effective Protection against Anthracycline Cardiotoxicity.
J Pharmacol Exp Ther;
373(3): 402-415, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253261
4.
In vitro and in vivo investigation of cardiotoxicity associated with anticancer proteasome inhibitors and their combination with anthracycline.
Clin Sci (Lond);
133(16): 1827-1844, 2019 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31409729
5.
Cardioprotective effects of inorganic nitrate/nitrite in chronic anthracycline cardiotoxicity: Comparison with dexrazoxane.
J Mol Cell Cardiol;
91: 92-103, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26724189
6.
Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model.
Exp Cell Res;
339(2): 174-86, 2015 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26515555
7.
Exploring the effects of topoisomerase II inhibitor XK469 on anthracycline cardiotoxicity and DNA damage.
Toxicol Sci;
198(2): 288-302, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38290791
8.
Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model.
Front Pharmacol;
14: 1298172, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38235109
9.
Chronic anthracycline cardiotoxicity: molecular and functional analysis with focus on nuclear factor erythroid 2-related factor 2 and mitochondrial biogenesis pathways.
J Pharmacol Exp Ther;
343(2): 468-78, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22915767
10.
Corrigendum to: "Proteomic investigation of embryonic rat heart-derived H9c2 cell line sheds new light on the molecular phenotype of the popular cell model" [Exp. Cell Res. 339 2 (2015) 174-186].
Exp Cell Res;
343(2): 267, 2016 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27155561
11.
Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts.
Can J Physiol Pharmacol;
90(9): 1303-10, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22913659
12.
Proteomic insights into chronic anthracycline cardiotoxicity.
J Mol Cell Cardiol;
50(5): 849-62, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21284945
13.
In vivo and in vitro assessment of the role of glutathione antioxidant system in anthracycline-induced cardiotoxicity.
Arch Toxicol;
85(5): 525-35, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21046361
14.
Development of water-soluble prodrugs of the bisdioxopiperazine topoisomerase IIß inhibitor ICRF-193 as potential cardioprotective agents against anthracycline cardiotoxicity.
Sci Rep;
11(1): 4456, 2021 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-33627707
15.
Clinically Translatable Prevention of Anthracycline Cardiotoxicity by Dexrazoxane Is Mediated by Topoisomerase II Beta and Not Metal Chelation.
Circ Heart Fail;
14(11): e008209, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551586
16.
Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury.
Chem Res Toxicol;
23(6): 1105-14, 2010 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-20521781
17.
Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron.
Pharmacol Rep;
61(1): 154-71, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19307704
18.
Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo.
J Pharmacol Exp Ther;
326(1): 259-69, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18434588
19.
New iron chelators in anthracycline-induced cardiotoxicity.
Cardiovasc Toxicol;
7(2): 145-50, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-17652820
20.
In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity.
Toxicology;
237(1-3): 218-228, 2007 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-17587482